Hikmetullah Batgi

4PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 25, 2020
Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience

Hikmettullah Batgi, Semih Başcı, Mehmet Sinan Dal

|Feb 27, 2020
The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience.

Hikmettullah Batgi, Alparslan Merdin, Mehmet Sinan Dal

|Feb 08, 2020
A multiple myeloma patient who developed ischemic colitis during lenalidomide treatment: A rare case report.

Hikmettullah Batgi, Mehmet Sinan Dal, Alparslan Merdin

|Dec 12, 2019
Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor.

Alparslan Merdin, Merih Kızıl Çakar, Mehmet Sinan Dal

Pageof 1

Frequent Collaborators

3 joint publications

Merih Kızıl Çakar

2 joint publications

Alparslan Merdin

1 joint publications

Semih Başcı

1 joint publications

Mehmet Sinan Dal